中金公司(601995.SH):海爾金盈的減持計劃實施期限已屆滿
格隆匯12月16日丨中金公司(601995.SH)公佈,公司此前已披露《中金公司持股5%以上股東減持股份進展公吿》(公吿編號:2022-020),2022年6月20日至6月28日期間,海爾金盈通過大宗交易方式累計減持9355萬股公司A股股份,佔公司總股本的1.94%。該公吿披露後至今,海爾金盈未進一步減持公司股份。截至公吿披露日,此次減持計劃的實施期限已屆滿。
此次減持計劃實施前,海爾金盈持有3.985億股公司A股股份,佔公司總股本的8.26%。此次減持計劃實施後,海爾金盈持有3.0495億股公司A股股份,佔公司總股本的6.32%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.